1931 — IVD Medical Holding Balance Sheet
0.000.00%
- HK$8.99bn
- HK$10.40bn
- CNY3.16bn
- 48
- 20
- 55
- 33
Annual balance sheet for IVD Medical Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 789 | 835 | 1,021 | 1,225 | 1,774 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 436 | 555 | 568 | 533 | 486 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,104 | 2,532 | 2,475 | 2,982 | 3,717 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 86.6 | 71.7 | 83.1 | 91.4 | 104 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,907 | 4,367 | 4,314 | 4,785 | 5,524 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 691 | 1,156 | 945 | 1,199 | 1,547 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 1,056 | 1,388 | 1,161 | 1,440 | 1,809 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2,851 | 2,979 | 3,153 | 3,345 | 3,715 |
| Total Liabilities & Shareholders' Equity | 3,907 | 4,367 | 4,314 | 4,785 | 5,524 |
| Total Common Shares Outstanding |